Insider Transactions Reported by 17 Insiders of POINT Biopharma Global Inc.

Location
Indianapolis, IN

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

POINT Biopharma Global Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Kolchinsky Chief Executive Officer, Director $13,674,059 29 Jun 2021
RA CAPITAL MANAGEMENT, L.P. Director $13,674,059 29 Jun 2021
Neil E. Fleshner Chief Medical Officer, Director 22 Dec 2023
Allan C. Silber Executive Chairman, Director 22 Dec 2023
BVF PARTNERS L P/IL Former 10% Owner 18 Dec 2023
Yael Margolin Director 27 Dec 2023
Bridget A. Martell Director 13 Jun 2023
Gerald L. Hogue Director 26 Dec 2023
Jessica D. Jensen EVP Clinical Development 27 Dec 2023
Joe A. McCann Chief Executive Officer, Director 22 Dec 2023
Justyna Kelly Chief Operating Officer 27 Dec 2023
Jonathan R. Goodman Director 26 Dec 2023
Rajesh Malik Director 26 Dec 2023
David Charles Lubner Director 26 Dec 2023
Michael M. Gottlieb Chief Commercial Officer 06 Jul 2021
Margaret E. Gilmour Director 06 Jul 2021
William L. Demers Chief Financial Officer 27 Dec 2023

Recent Insider Transactions by Companies or Individuals for POINT Biopharma Global Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.